GMAB News
Genmab A/S
$37.71
+$0.82(+2.22%)
61
Overall
60
Value
75
Tech
50
Quality
Market Cap
$23.02B
Volume
814.67K
52W Range
$23.62 - $40.17
Target Price
$43.22
GMAB news: the latest Genmab A/S headlines, press releases and market updates, newest first.
Latest GMAB News
- Genmab (GMAB) Receives a Buy from Truist FinancialTipRanks Auto-Generated Intelligence Newsdesk · Oct 9, 2026
- Genmab Grants Restricted Stock Units to Board After Extraordinary General MeetingTipRanks Auto-Generated Newsdesk · Oct 7, 2026
- TD Cowen Sticks to Their Buy Rating for Genmab (GMAB)TipRanks Auto-Generated Intelligence Newsdesk · Oct 5, 2026
- Genmab and AbbVie Report Landmark Phase 3 Win for Epcoritamab Combo in Frontline DLBCLTipRanks Auto-Generated Newsdesk · Oct 5, 2026
- Genmab A/S (0MGB) Receives a Buy from JefferiesTipRanks Auto-Generated Intelligence Newsdesk · Oct 5, 2026
- Analysts Conflicted on These Healthcare Names: Pfizer (PFE) and Genmab (GMAB)TipRanks Newsroom · Oct 5, 2026
- Genmab Discloses Darwin Global as 5.11% Major ShareholderTipRanks Auto-Generated Newsdesk · Oct 2, 2026
- Genmab Updates Capital Structure and Articles of Association in September 2026 SEC FilingTipRanks Auto-Generated Newsdesk · Sep 29, 2026
- Bank of America Securities Sticks to Their Buy Rating for Genmab A/S (0MGB)TipRanks Auto-Generated Intelligence Newsdesk · Sep 25, 2026
- Genmab Grants New Employee Restricted Stock Units and WarrantsTipRanks Auto-Generated Newsdesk · Sep 24, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GMAB | $37.71 | +2.2% | 814.67K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |